Protara Therapeutics, Inc. (TARA) Profit Breakdown
- 2026-06-30: Reportable Segment, Aggregation before Other Operating -$21.67M.
- 2025-06-30: Reportable Segment, Aggregation before Other Operating -$14.96M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2012-12-31 to 2026-06-30
- Data captured
Profit by product
Net Income (Loss) Attributable to Parent: each quarter (3 month)
| Quarter end | Reportable Segment, Aggregation before Other Operating |
|---|
| 2026-06-30 | -$21.67M |
|---|
| 2025-06-30 | -$14.96M |
|---|
Nonoperating Income (Expense): each quarter (3 month)
| Quarter end | Reportable Segment, Aggregation before Other Operating |
|---|
| 2026-06-30 | $1.66M |
|---|
| 2025-06-30 | $1.63M |
|---|
Operating income: each quarter (3 month)
| Quarter end | Reportable Segment, Aggregation before Other Operating |
|---|
| 2026-06-30 | -$23.32M |
|---|
| 2025-06-30 | -$16.59M |
|---|